Role of reactive oxygen metabolites in the pathogenesis of chronic inflammatory bowel disease
Fernández-Bañares, F.
Gastroenterologia y Hepatologia 18(10): 526-536
1995
ISSN/ISBN: 0210-5705 PMID: 8548589 Document Number: 450039
Document emailed within 1 workday
Related Documents
Moulton, P.J. 1996: Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species British Journal of Biomedical Science 53(4): 317-324Selivanova, L.S.; Tertychnyy, A.S. 2016: The Role of the Neuroendocrine System in the Pathogenesis of Inflammatory Bowel Disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 12(12): 92-96
Kolacek, S. 2002: Role of enteral nutrition in the treatment of chronic inflammatory bowel disease Medicinski Arhiv 56(1 Suppl 1: 21-22
Quah, S.H. 2013: Role of probiotics and nutrition in the management of chronic inflammatory bowel disease in children Singapore Medical Journal 54(4): 183-184
Svendsen, J.H. 1994: The microcirculation of the heart. With special reference to the role of reactive oxygen metabolites in the microvascular reperfusion injury Danish Medical Bulletin 41(5): 526-540
Shlafer, M.; Kane, P.F.; Wiggins, V.Y.; Kirsh, M.M. 1982: Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury Circulation 66(2 Part 2): I85-I92
Gayá, A. 1995: Characteristics of lymphocyte populations and macrophages of the lamina propria in chronic inflammatory bowel disease. the role of cytokines Gastroenterologia y Hepatologia 18(10): 510-514
Nassif, J.; Abbasi, S.A.; Nassar, A.; Abu-Musa, A.; Eid, A.A. 2016: The role of NADPH-derived reactive oxygen species production in the pathogenesis of endometriosis: a novel mechanistic approach Journal of Biological Regulators and Homeostatic Agents 30(1): 31-40
Renke, J.; Popadiuk, S.; Wozniak, Mł.; Szlagatys-Sidorkiewicz, A.; Hansdorfer-Korzon, R. 2006: Mast cells, their adenosine receptors and reactive oxygen species in chronic inflammatory pathologies of childhood Przeglad Lekarski 63(7): 554-556
Neurath, M.F. 1998: Pathogenesis of inflammatory bowel disease: transcription factors in the spotlight Gut 42(4): 458-459
Greenstein, A.J.; Aufses, A.H. 1985: Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease Surgery Gynecology and Obstetrics 160(1): 63-69
Cekic, C.; Arabul, M.; Alper, E.; Pakoz, Z.B.K.; Saritas, E.; Yuksel; Ünsal, B. 2014: Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases Hepato-Gastroenterology 61(133): 1196-1200
El-Kadi, A.O.; Bleau, A.M.; Dumont, I.; Maurice, H.; du Souich, P. 2000: Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(9): 1112-1120
Morelli, M.S.; Zucker, S.D. 2003: A role for the appendix in inflammatory bowel disease? Cut it out Gastroenterology 125(4): 1270-2; Discussion 1272
Nielsen, S.E.øe.; Nielsen, O.H.; Vainer, B.; Claesson, M.H. 2002: Inflammatory bowel disease--do microorganisms play a role? Ugeskrift for Laeger 164(50): 5947-5950
Seegert, D.; Schreiber, S. 2002: Overview: interleukin-16 and its role in inflammatory bowel disease Current Opinion in Investigational Drugs 3(4): 562-564
Su, C.G..; Judge, T.A..; Lichtenstein, G.R.. 2001: The role of biological therapy in inflammatory bowel disease Drugs of Today 37(2): 121-133
Ashida, T. 2008: Inflammatory bowel disease--the role and issue of glucocorticoid Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 137-141
Kruszewski, J.; Wasek, Z.; Płusa, T. 1983: Role of arachidonic acid (ETE) and its metabolites in the pathogenesis of bronchial spasm. I. Metabolites formed under the effect of cyclooxygenase Pneumonologia Polska 51(11): 585-589
Limberg, B. 1999: Diagnosis of chronic inflammatory bowel disease by ultrasonography Zeitschrift für Gastroenterologie 37(6): 495-508